NovelStem International Corp. (NSTM): Cash & Equivalents

Annual figures by period end, from SEC filings.

$6.1K
As of 2024-12-31
-11.0%
3-year compound annual growth
$29.41M2009-12-31: $8.37M2010-12-31: $29.41M2011-12-31: $3.68M2012-12-31: $11.38M2021-12-31: $8.7K2022-12-31: $6.3K2023-12-31: $53.1K2024-12-31: $6.1K$6.1K
2009-12-31 Cash & Equivalents (USD) 2024-12-31
Period endedCash & EquivalentsChange YoYSource filing
2024-12-31$6.1K-88.5%2025-04-07, Balance as of period end
2023-12-31$53.1K+736.2%2025-04-07, Balance as of period end
2022-12-31$6.3K-26.8%2023-03-31, Balance as of period end
2021-12-31$8.7Kn/a2023-03-31, Balance as of period end
No annual figure between 2012-12-31 and 2021-12-31.
2012-12-31$11.38M+208.9%2013-04-01, Balance as of period end
2011-12-31$3.68M-87.5%2013-04-01, Balance as of period end
2010-12-31$29.41M+251.5%2012-04-16, Balance as of period end
2009-12-31$8.37Mn/a2012-04-16, Balance as of period end